How Hemophilia is Treated

Hemophilia is medically managed by replacing the missing clotting factor in the blood through intravenous infusion. Bleeding stops when adequate clotting factor levels reach the bleeding site. Immediate treatment during acute bleeds is vital to prevent permanent joint and tissue damage.

Primary Treatment Modalities (by Factor Concentration):

Recombinant & Plasma-Derived Factor Concentrates: Gold standard treatment of choice.
Cryoprecipitate: Concentrated fraction of plasma containing Factor VIII and Fibrinogen.
Fresh Frozen Plasma (FFP): Contains unseparated plasma coagulation factors.

1. Clotting Factor Concentrates

Factor concentrates are the safest and most effective therapy for Hemophilia A (Factor VIII) and Hemophilia B (Factor IX):

Plasma-Derived Concentrates: Extracted from pooled human donor plasma and subjected to advanced viral inactivation (heat/pasteurization and solvent-detergent methods).
Recombinant Factor Concentrates: Bioengineered without human blood components using advanced genetic engineering techniques.

2. Desmopressin (DDAVP)

For patients with mild Hemophilia A, Desmopressin (DDAVP)—a synthetic analog of vasopressin—can be administered intravenously, subcutaneously, or via nasal spray to stimulate the release of endogenous stored Factor VIII and von Willebrand factor.

3. Antifibrinolytic Medications

Medicines such as Tranexamic Acid and Aminocaproic Acid help stabilize clots and prevent premature clot breakdown. They are particularly beneficial as adjunctive therapy during dental procedures, mouth bleeds, or nosebleeds.

4. Physiotherapy & Comprehensive Care

Regular physical therapy is essential to preserve range of motion, strengthen supporting musculature, and prevent arthropathy (chronic joint damage) in knees, elbows, and ankles. The Hemophilia Society Rajkot provides daily free physiotherapy for all registered patients.